Exposure to FKN may result in epithelial-to-mesenchymal transition (EMT) with enhanced CX3CR1+ cell migration, which is symptomatic of increased invasive and metastatic potential during prostate cancer progression. This evidence concerns the gene CX3CR1 and prostate cancer.